시장보고서
상품코드
1448398

세계의 질염 치료제 시장 규모, 점유율, 성장 분석 : 유형별, 치료법별, 유통 채널별 - 산업 예측(2024-2031년)

Global Vaginitis Therapeutics Market Size, Share, Growth Analysis, By Type, By Treatment, By Distribution channel - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 219 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 질염 치료제 시장 규모는 2022년 4억 4,000만 달러로 예측 기간(2024-2031년) 동안 25.6%의 CAGR로 2023년 5억 5,000만 달러에서 2031년 34억 2,000만 달러로 성장할 것으로 예상됩니다.

질 감염에 걸리는 사람이 증가함에 따라 질 감염 치료 세계 시장이 확대되고 있습니다. 시장은 항균제와 프로바이오틱스 사용에 중점을 둔 개별화되고 덜 침습적인 치료법으로 전환하고 있습니다. 새로운 기술은 새로운 치료법과 감염을 진단하는 도구를 개발하는 데 도움이 되고 있습니다. 시장의 주요 기업들은 연구에 자금을 투자하고 더 많은 제품을 만들기 위해 다른 회사와 협력하고 있습니다. 북미와 유럽은 의료 시스템이 잘 갖추어져 있고 사람들이 감염성 질환에 대해 잘 알고 있기 때문에 시장의 대부분을 차지하고 있습니다. 그러나 빠르게 발전하는 아시아태평양 국가에서는 더 많은 사람들이 의료 서비스를 받고 이러한 감염성 질환에 대해 배우고 있기 때문에 큰 성장이 예상됩니다.

목차

주요 요약

  • 시장 개요
  • 향후 전망

조사 방법

  • 정보 조달
  • 2차·1차 정보 출처
  • 시장 규모 추정
  • 시장 가정과 제한

상부 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porters 분석
  • 향후 혼란에 대한 특별한 인사이트

질염 치료제 세계 시장 : 유형별

  • 시장 개요
  • 세균성 질염
  • 이스트균감염증
  • 트리코모나스증

질염 치료제 세계 시장 : 치료법별

  • 시장 개요
  • 항진균제·항생제 약물
  • 국소 크림
  • 가정 요법

질염 치료제 세계 시장 : 유통 채널별

  • 시장 개요
  • 약국
  • E-Commerce
  • 소매점

질염 치료제 세계 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카(MEA)
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 상황

  • 상위 5개사의 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채용한 전략
  • 주요 성공 전략
  • 시장의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • Pfizer Inc.(USA)
  • Johnson & Johnson(USA)
  • Novartis AG(Switzerland)
  • GlaxoSmithKline plc(UK)
  • Bayer AG(Germany)
  • Sanofi(France)
  • Merck & Co., Inc.(USA)
  • Eli Lilly and Company(USA)
  • AstraZeneca plc(UK/Sweden)
  • AbbVie Inc.(USA)
  • Gilead Sciences, Inc.(USA)
  • Roche Holding AG(Switzerland)
  • Bristol Myers Squibb(USA)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Astellas Pharma Inc.(Japan)
  • Mylan N.V.(USA)
  • Daiichi Sankyo Co., Ltd.(Japan)
  • Takeda Pharmaceutical Company Limited(Japan)
  • Boehringer Ingelheim(Germany)
  • Sun Pharmaceutical Industries Ltd.(India)
ksm 24.04.11

Global Vaginitis Therapeutics market size was valued at USD 0.44 billion in 2022 and is poised to grow from USD 0.55 billion in 2023 to USD 3.42 billion by 2031, at a CAGR of 25.6% during the forecast period (2024-2031).

The worldwide market for treating vaginal infections is growing because more people are getting these infections. The market is moving towards treatments that are personalized and less invasive, with a focus on using antimicrobial drugs and probiotics. New technology is helping create new treatments and tools for diagnosing infections. Big companies in the market are spending money on research and working with others to make more products. North America and Europe have big parts of the market because they have good healthcare systems and people know about these infections. But countries in Asia-Pacific that are developing quickly could see big growth because more people are getting access to healthcare and learning about these infections.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vaginitis Therapeutics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vaginitis Therapeutics Market Segmental Analysis

The global vaginitis therapeutics market is segmented on the basis of type, treatment, distribution channel, and region. By Type, the market is segmented into bacterial vaginosis, yeast infection, and trichomoniasis. By Treatment, the market is segmented into antifungal and antibiotic medications, topical creams, and home remedies. By Distribution channel, the market is segmented into pharmacies, e-commerce, and retail stores. By Region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Drivers of the Global Vaginitis Therapeutics Market

Vaginitis, which includes different types of vaginal infections and inflammation, is a common problem for women all over the world. Many women have it, so there's a big need for treatments that work well. Things like not keeping clean, using some types of birth control, taking antibiotics, and changes in hormones can make vaginitis more likely to happen.

Restraints in the Global Vaginitis Therapeutics Market

Antibiotics are often used to treat bacterial vaginosis, a type of vaginitis. But using antibiotics too much or not in the right way has made some bacteria become resistant to them. This means antibiotics might not work as well to treat bacterial vaginosis, and it can be harder to manage the infection.

Market Trends of the Global Vaginitis Therapeutics Market

A big trend in treating vaginal infections is that more women are learning about their reproductive health. They want to know more about how to find out if they have an infection, how to treat it, and how to stop it from happening again. Because of this, more women might see a doctor early on if they think they have an infection, which means there's a bigger need for treatments that work well.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Vaginitis Therapeutics Market by Type

  • Market Overview
  • Bacterial vaginosis
  • yeast infection
  • and trichomoniasis

Global Vaginitis Therapeutics Market by Treatment

  • Market Overview
  • Antifungal and antibiotic medications
  • topical creams
  • and home remedies

Global Vaginitis Therapeutics Market by Distribution channel

  • Market Overview
  • Pharmacies
  • e-commerce
  • and retail stores

Global Vaginitis Therapeutics Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Pfizer Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca plc (UK/Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AbbVie Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gilead Sciences, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol Myers Squibb (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Astellas Pharma Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan N.V. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Daiichi Sankyo Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company Limited (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제